Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Behr-Gross Me"'
Publikováno v:
Transfusion Clinique et Biologique. 20:127-138
In November 2009, the Council of Europe's Blood Transfusion Steering Committee created a group of experts to explore the problem of behaviors having an impact on the management of donors of blood a ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0254985868ea245ca3fb0491252e721
https://doi.org/10.1016/j.tracli.2013.03.002
https://doi.org/10.1016/j.tracli.2013.03.002
Publikováno v:
Vox Sanguinis. 85:313-321
Background and Objectives The aim of the study was to evaluate a lyophilized anti-D immunoglobulin preparation to serve as a global standard for potency assays of anti-D immunoglobulin products. Materials and Methods The candidate global standard, 01
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5e80621ad1f45a9e4ea5f9d85517fc3
https://doi.org/10.1111/j.0042-9007.2003.00367.x
https://doi.org/10.1111/j.0042-9007.2003.00367.x
Publikováno v:
Vox sanguinis. 107(4)
One of the most controversial policies in blood transfusion worldwide is the permanent deferral from donating blood of men with sexual contacts to other men (MSM). This policy was implemented for safety reasons as sex between men is known to be a hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d60e610230fa8d93fa11e074797d26ca
https://pubmed.ncbi.nlm.nih.gov/25040600
https://pubmed.ncbi.nlm.nih.gov/25040600
Autor:
Bernard Fox, Alan Heath, Susan J. Thorpe, M. L. Virata-Theimer, E. Terao, Behr-Gross Me, M. W. Yu, Giles Sharp
Publikováno v:
Vox sanguinis. 97(2)
Background and Objectives The aim of the study was to evaluate, in an international collaboration, three lyophilized intravenous immunoglobulin (IVIG) preparations for their suitability to standardize and control haemagglutination testing for anti-A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b9d003bb06c7ccc7784637a8600e343
https://pubmed.ncbi.nlm.nih.gov/19402856
https://pubmed.ncbi.nlm.nih.gov/19402856
Publikováno v:
Vox sanguinis. 88(2)
Background and Objectives The aim of this study was to replace the 1st International Standard (IS) for prekallikrein activator (PKA) (code 82/530) with a new IS and European Biological Reference Preparation (BRP). The new standards were freeze dried
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::378790c5878a988c1af30994738c8e55
https://pubmed.ncbi.nlm.nih.gov/15720613
https://pubmed.ncbi.nlm.nih.gov/15720613
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Behrensdorf-Nicol H; Paul-Ehrlich-Institut, Paul-Ehrlich-Strasse 51-59, D-63225 Langen, Germany., Krämer B; Paul-Ehrlich-Institut, Paul-Ehrlich-Strasse 51-59, D-63225 Langen, Germany., Le Tallec D; European Directorate for the Quality of Medicines & HealthCare (EDQM), Department of Biological Standardisation, OMCL Network & HealthCare (DBO), Council of Europe, Strasbourg, France., Sinitskaya N; European Directorate for the Quality of Medicines & HealthCare (EDQM), Department of Biological Standardisation, OMCL Network & HealthCare (DBO), Council of Europe, Strasbourg, France., Behr-Gross ME; European Directorate for the Quality of Medicines & HealthCare (EDQM), Department of Biological Standardisation, OMCL Network & HealthCare (DBO), Council of Europe, Strasbourg, France.
Publikováno v:
Pharmeuropa bio & scientific notes [Pharmeur Bio Sci Notes] 2024; Vol. 2024, pp. 127-161.
Autor:
Behrensdorf-Nicol H; Paul-Ehrlich-Institut, Paul-Ehrlich-Strasse 51-59, D-63225 Langen, Germany., Le Tallec D; European Directorate for the Quality of Medicines & HealthCare (EDQM), Department of Biological Standardisation, OMCL Network & HealthCare (DBO), Council of Europe, Strasbourg, France., Sinitskaya N; European Directorate for the Quality of Medicines & HealthCare (EDQM), Department of Biological Standardisation, OMCL Network & HealthCare (DBO), Council of Europe, Strasbourg, France., Behr-Gross ME; European Directorate for the Quality of Medicines & HealthCare (EDQM), Department of Biological Standardisation, OMCL Network & HealthCare (DBO), Council of Europe, Strasbourg, France., Göngrich C; European Directorate for the Quality of Medicines & HealthCare (EDQM), Department of Biological Standardisation, OMCL Network & HealthCare (DBO), Council of Europe, Strasbourg, France.
Publikováno v:
Pharmeuropa bio & scientific notes [Pharmeur Bio Sci Notes] 2024; Vol. 2024, pp. 162-192.